Protagonist Therapeutics (PTGX) PT Lowered to $60 at Piper Sandler

May 6, 2022 6:29 AM EDT Send to a Friend

Piper Sandler analyst Yasmeen Rahimi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Protagonist Therapeutics (PTGX) PT Lowered to $60 at Piper Sandler

Member Login

Free News Feed